A Single Nucleotide Polymorphism (SNP) is the most common type of genetic variation found within a genome. It occurs when a single nucleotide (A, T, C, or G) at a specific position in the DNA sequence differs among individuals. These variations may arise through the substitution, insertion, or deletion of a single nucleotide and contribute significantly to genetic diversity within populations.
Most SNPs are bi-allelic, meaning that only two alternative nucleotide forms are present at a given genomic location. Although tri-allelic and tetra-allelic SNPs can occur, they are extremely uncommon and have limited relevance in most genetic studies. Consequently, the majority of SNP analyses focus on bi-allelic variants.
Single nucleotide substitutions are broadly classified into two categories:
Among these mutation types, transitions occur much more frequently than transversions, accounting for approximately two-thirds of all naturally occurring SNPs. Owing to their abundance and stability, SNPs serve as valuable genetic markers for genome-wide association studies (GWAS), population genetics, molecular breeding, disease susceptibility research, pharmacogenomics, and precision medicine.
Single Nucleotide Polymorphisms (SNPs) are among the most informative genetic markers used in modern genomics. Although many SNPs occur within non-coding regions of the genome, some are located in protein-coding or regulatory regions, where they can influence gene function, gene expression, and ultimately affect biological traits or disease susceptibility. Identifying these genetic variations provides valuable insights into the molecular basis of health, disease, and phenotypic diversity.
As third-generation molecular markers, SNPs are abundantly distributed throughout the genomes of humans, animals, and plants. Their widespread occurrence, low mutation rate, high genetic stability, and compatibility with automated high-throughput technologies make them ideal markers for large-scale genetic studies.
Importantly, not every SNP directly causes a biological effect. Many SNPs are inherited together with nearby functional or disease-associated genes through linkage disequilibrium (LD). As a result, these variants serve as reliable genetic markers for locating genomic regions associated with important traits and diseases, even when they are not themselves functionally responsible.
SNP genotyping plays a critical role in numerous research and applied genomics applications, including:
With its exceptional accuracy, scalability, and reproducibility, SNP genotyping has become an indispensable tool for genetic research, molecular diagnostics, agricultural biotechnology, and personalized healthcare.
Microarray technology is a powerful and established approach for high-throughput SNP genotyping when the target genetic markers are already known. By enabling the simultaneous analysis of thousands to millions of SNPs in a single experiment, SNP microarrays provide an accurate, efficient, and cost-effective solution for large-scale genetic studies.
The technology is based on the principle of DNA hybridization, where labeled DNA samples bind to complementary oligonucleotide probes immobilized on a solid microarray surface. Each probe is designed to target a specific SNP locus, allowing the genotype of numerous variants to be determined simultaneously. Depending on the selected platform, a single microarray can interrogate 5,000 to over one million SNP markers in a single sample.
At N2Jenomics Lab Pvt. Ltd., we offer comprehensive microarray-based SNP genotyping services using industry-leading Affymetrix® (Thermo Fisher Scientific) and Illumina® genotyping platforms.
Our Affymetrix® services utilize the GeneTitan™ Multi-Channel Instrument and GeneChip™ Scanner platforms, supporting a wide range of applications from targeted SNP analysis to genome-wide genotyping. Multiple pre-designed Axiom™ array formats are available for human, animal, plant, and model organism research, enabling flexible project design across varying sample sizes.
Illumina® Infinium™ and BeadArray technologies provide ultra-high-density SNP genotyping suitable for:
These arrays deliver highly reproducible results while accurately detecting both SNPs and structural genomic variations.
Commercial SNP arrays are available for numerous organisms, including:
For species without commercially available SNP arrays, alternative sequencing-based genotyping approaches may provide greater flexibility.
Analyze thousands to over one million SNP markers simultaneously in a single experiment, making microarrays ideal for large-scale genomic studies.
Standardized manufacturing processes and stringent quality control ensure highly reproducible genotype calls across experiments and laboratories.
Optimized workflows enable rapid processing, with many projects completed within only a few days depending on project size.
Microarrays offer excellent value for projects requiring genome-wide analysis of large sample cohorts, significantly reducing the cost per data point.
Established analysis pipelines and standardized output formats facilitate downstream bioinformatics, data sharing, and cross-study comparisons.
High-density probe design provides comprehensive genomic coverage, supporting robust association studies and genetic mapping.
Note: Commercial SNP arrays contain predefined probe sets and therefore offer limited flexibility for adding custom markers. For non-model organisms or highly customized studies, sequencing-based SNP genotyping may be a more suitable alternative.
Next-Generation Sequencing (NGS) has transformed SNP genotyping by enabling simultaneous discovery and genotyping of thousands to millions of genetic variants across the genome. Unlike SNP arrays, NGS is not limited to predefined markers, making it particularly valuable for variant discovery, non-model organisms, and customized genomic studies.
NGS sequences millions of DNA fragments in parallel, generating large volumes of genomic data with exceptional throughput. This technology supports comprehensive analysis of coding and non-coding regions and has become an indispensable tool in human, animal, plant, and microbial genomics.
Although NGS typically generates shorter sequencing reads than long-read sequencing technologies, advances in sequencing chemistry and bioinformatics continue to improve accuracy, sensitivity, and variant detection performance.
Whole-Genome Sequencing provides complete coverage of both coding and non-coding regions, enabling comprehensive identification and genotyping of genetic variants across the entire genome. WGS is the preferred approach for genome-wide variant discovery and population genomics.
Whole-Exome Sequencing focuses exclusively on protein-coding regions of the genome. Since many disease-associated variants occur within exons, WES offers a cost-effective strategy for identifying functional SNPs involved in inherited disorders and complex diseases.
Targeted sequencing selectively analyzes predefined genes, genomic regions, or candidate SNPs. This approach delivers deep sequencing coverage and high analytical sensitivity while reducing sequencing costs compared with whole-genome analysis.
Although primarily used for transcriptome profiling, RNA-Seq can also identify expressed SNPs and allele-specific expression patterns, providing insights into functional genetic variation at the transcript level.
Modern NGS platforms support simultaneous sequencing of numerous indexed samples within a single run. Multiplexing significantly improves throughput while lowering the cost per sample, making it particularly valuable for GWAS and large-scale population studies.
GBS is a reduced-representation sequencing method that combines restriction enzyme digestion with NGS to efficiently identify and genotype SNPs across many individuals. It is widely used in plant breeding, animal genetics, and population genomics.
ddRAD-Seq utilizes two restriction enzymes to generate reproducible subsets of genomic fragments for sequencing. This technique enables accurate SNP discovery and genotyping while reducing sequencing costs and computational complexity.
2b-RAD is another reduced-representation sequencing approach that employs Type IIB restriction enzymes to generate uniformly sized DNA fragments for sequencing. It offers an efficient and economical solution for SNP discovery and genotyping in both model and non-model organisms, making it particularly useful for evolutionary biology, ecological genomics, and breeding applications.
Polymerase Chain Reaction (PCR)-based methods are widely used for targeted SNP genotyping due to their high sensitivity, rapid turnaround time, and cost-effectiveness. These techniques are particularly suitable for studies involving a limited number of SNP markers and provide reliable results using relatively small amounts of DNA.
PCR-based assays are generally completed within a few hours and are easy to implement in routine molecular biology laboratories. While they offer excellent accuracy for targeted applications, they are less suitable for genome-wide analysis because they typically evaluate a limited number of loci and cannot simultaneously identify novel genetic variants.
Ligase Detection Reaction (LDR) is a targeted SNP genotyping technique that utilizes DNA ligase to discriminate between alleles with high specificity. Two adjacent probes hybridize to the target DNA, and ligation occurs only when the probes perfectly match the nucleotide sequence at the SNP position. The ligated products are subsequently detected by fluorescence-based fragment analysis, enabling accurate identification of SNP genotypes.
SNaPshot® technology combines multiplex PCR with single-base primer extension to genotype multiple known SNPs in a single reaction. Following PCR amplification, allele-specific extension primers incorporate one fluorescently labeled dideoxynucleotide (ddNTP) complementary to the target SNP. The extension products are separated by capillary electrophoresis, and fluorescent signals are analyzed to determine the genotype of each sample.
TaqMan® SNP Genotyping employs allele-specific fluorescent probes during real-time PCR to accurately identify genetic variants. During amplification, perfectly matched probes are cleaved by the 5′→3′ exonuclease activity of Taq DNA polymerase, releasing fluorescent signals that enable automated genotype determination.
PCR-ARMS is an allele-specific PCR method designed to selectively amplify DNA fragments containing a particular SNP or mutation. Carefully designed primers ensure amplification occurs only when the target allele is present, making the technique highly effective for detecting known variants.
• PCR-based SNP genotyping methods provide researchers with flexible, accurate, and economical solutions for targeted genetic analysis. The choice of technology depends on factors such as the number of SNPs, sample size, throughput requirements, and overall project objectives.
MassARRAY® SNP Genotyping combines Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) with PCR and single-base extension chemistry to deliver highly accurate targeted SNP analysis.
The workflow begins with PCR amplification of genomic regions containing the SNPs of interest. A single-base extension reaction is then performed using sequence-specific primers. The extension products are analyzed by MALDI-TOF mass spectrometry, where nucleic acid molecules are ionized and separated according to their molecular mass. Because each nucleotide has a distinct molecular weight, the system accurately distinguishes alleles and determines SNP genotypes with exceptional precision.
MassARRAY® technology offers excellent multiplexing capability and is particularly well suited for medium- to high-throughput projects involving multiple SNP markers across large sample populations.
N2Jenomics Lab Pvt. Ltd. offers comprehensive SNP genotyping solutions using a wide range of validated technologies, including PCR-based assays, MassARRAY®, microarray platforms, and next-generation sequencing (NGS). Our experienced team of molecular biologists and bioinformatics specialists works closely with researchers to recommend the most appropriate genotyping strategy based on project goals, sample size, target SNPs, turnaround time, and budget.
With advanced laboratory infrastructure, optimized workflows, and stringent quality control standards, we deliver accurate, scalable, and cost-effective SNP genotyping services that support applications in human genetics, agricultural genomics, molecular breeding, disease research, pharmacogenomics, population genetics, and precision medicine.
| Method | Genome-wide | Fragment Source | Size Selection | Throughput | Best Use Case |
|---|---|---|---|---|---|
| RAD-seq (classic) | ✅ Yes | Single enzyme + random shearing | Physical shearing | Medium | Non-model species without reference genome |
| ddRAD-seq | ✅ Yes | Two enzymes + size-selected fragments | Gel-based, precise range | High | Balanced SNP discovery with uniform coverage |
| 2b-RAD | ✅ Yes | Type IIB enzyme → uniform 33–36 bp tags | No size selection needed | Very High | High-density SNP mapping, even on degraded DNA |
| PCR-LDR Genotyping | ❌ Targeted only | PCR + ligase detection | N/A | Low | Validation of known SNPs for one or few loci |
| MassARRAY Genotyping | ❌ Targeted only | PCR + single-base extension + MALDI-TOF MS | PCR-based primers | Medium–High | Multiplex validation of ~10–100 SNPs |
Choose a method based on: